1.
Does use of ‘non-trial’ cessation support help explain the lack of effect from offering NRT to quitline callers in a RCT?
by Docherty, Graeme
Tobacco control, 2014, Vol.23 (6), p.524-525
2.
Methylcobalamin in Vitamin B12 Deficiency: To Give or not to Give?
by Kamath, Ashwin
Journal of pharmacology & pharmacotherapeutics, 2017, Vol.8 (1), p.33-34
3.
Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy
by Kate, Anahita
Journal of pharmacology & pharmacotherapeutics, 2016, Vol.7 (1), p.28-30
4.
Optimising 18F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
by Massaro, Arianna Arianna
North American journal of medical sciences, 2012, Vol.4 (9), p.416-420
5.
When a tax increase fails as a tobacco control policy: the ITC China project evaluation of the 2009 cigarette tax increase in China
by Li, Qiang
Tobacco control, 2012, Vol.21 (3), p.381-381
7.
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
by Rowbotham, Nicola J
Thorax, 2018, Vol.73 (4), p.388-390
8.
9.
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
by Waters, Elaine M
Thorax, 2017, Vol.72 (7), p.666-667
10.
Protective effects of apigenin against methyl methanesulfonate induced hsp70 expression in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ)Bg9
by Siddique, Yasir Hasan Yasir Hasan
Journal of pharmacology & pharmacotherapeutics, 2012, Vol.3 (2), p.188-190
11.
Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study
by Krogvold, Lars
Diabetologia, 2014, Vol.57 (4), p.841-843
12.
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
by Sax, Paul E
AIDS (London), 2018, Vol.32 (12), p.1723-1725
13.
Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions
by Cameron, Jennifer M
Tobacco control, 2014, Vol.23 (1), p.77-78
14.
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
by Richeldi, Luca
Thorax, 2018, Vol.73 (6), p.581-583
15.
Daily physical activity in subjects with newly diagnosed COPD
by Van Remoortel, Hans
Thorax, 2013, Vol.68 (10), p.962-963
16.
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
by Škrtić, Marko
Diabetologia, 2014, Vol.57 (12), p.2599-2602
17.
Incidence and recognition of acute respiratory distress syndrome in a UK intensive care unit
by Summers, Charlotte
Thorax, 2016, Vol.71 (11), p.1050-1051
18.
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
by Fioretto, Paola
Diabetologia, 2016, Vol.59 (9), p.2036-2039
19.
The impact of azithromycin therapy on the airway microbiota in asthma
by Slater, Mariel
Thorax, 2014, Vol.69 (7), p.673-674
20.
Validity and reliability of the Edmonton Frail Scale
by Rolfson, Darryl B.
Age and ageing, 2006, Vol.35 (5), p.526-529
